Despite the available clinical studies evaluating the potential role of hemostatis biomarkers (i.e., von Willebrand factor (vWF), P-selectin, fibrinogen, thrombomodulin, tissue factor, d-dimer, etc.)in ischemic stroke patients, the value of studied biomarkers is still unproven and requires further investigation [26]. Here, VWF is linked to ischemic stroke.